Newsroom
Please follow us on LinkedIn if you’d like to stay up-to-date with our latest news.
Press releases
Full Seracam® Characterisation Results Published in EJNMMI Physics
London, UK, 8 July 2024. Serac Imaging Systems Limited (“Serac Imaging Systems” or “the Company”), the medtech company developing a portable hybrid gamma-optical camera for medical imaging, announces today that the results from a full characterisation study of Seracam conducted by Loughborough University have been published in the latest edition of the EJNMMI Physics, a companion journal to the European Journal of Nuclear Medicine and Molecular Imaging (EJNMMI).
Abstracts Accepted at EANM and IPET Conferences Comparing Seracam® to Standard of Care Nuclear Medicine Imaging
London, UK, and Kuala Lumpur, Malaysia, 1 July 2024. Serac Imaging Systems Limited (“Serac Imaging Systems” or “the Company”), the medtech company developing a portable hybrid gamma-optical camera for medical imaging, and the University of Malaya Medical Centre, today announce that abstracts related to two ongoing clinical trials taking place in Malaysia using Seracam® have been accepted for presentation at key scientific meetings later this year.
First Use Of Seracam® In Image Guided Surgery
London, UK and Kuala Lumpur, Malaysia, 6 June 2024. Serac Imaging Systems Limited (“Serac Imaging
Systems” or “the Company”), the medtech company developing a portable hybrid gamma-optical
camera for medical imaging, and the University of Malaya Medical Centre, today announce the start
of clinical testing using Seracam® for image guided surgery in sentinel lymph node biopsy procedures
in patients with breast cancer.
Innovate UK grant awarded to develop Seracam® for image guided surgical oncology
London, UK, 26 March 2024. Serac Imaging Systems Limited (“Serac Imaging Systems” or “the
Company”), the medtech company developing Seracam®, a portable hybrid gamma-optical camera
for medical imaging, and Loughborough University announce that a grant has been awarded by
Innovate UK, the UK’s innovation agency, to Loughborough University to co-fund the development of
the camera for image guided surgery.
Icahn School of Medicine at Mount Sinai commences clinical testing with Seracam®
London, UK and New York, USA, 6 September 2023, Serac Imaging Systems Limited (“Serac Imaging Systems” or “the Company”), the medtech company developing Seracam®, a portable hybrid gamma-optical camera for medical imaging, and the Icahn School of Medicine at Mount Sinai, a ground-breaking leader in medical education, today announce the start of clinical testing using the Seracam® camera.
James Kaufman appointed as Chief Commercial Officer
London, UK, 20 June 2023. Serac Imaging Systems Limited (“Serac Imaging Systems” or “the Company”), the medical technology company developing Seracam®, a portable hybrid gamma-optical camera for medical imaging, today announces the appointment of James Kaufman as Chief Commercial Officer. James brings almost thirty years’ experience in the global healthcare and molecular imaging industry and will be responsible for leading on the commercialisation of Seracam®, reporting to Chief Executive, Mark Rosser.
Full Seracam® Characterisation Results Published in EJNMMI Physics
London, UK, 8 July 2024. Serac Imaging Systems Limited (“Serac Imaging Systems” or “the Company”), the medtech company developing a portable hybrid gamma-optical camera for medical imaging, announces today that the results from a full characterisation study of Seracam conducted by Loughborough University have been published in the latest edition of the EJNMMI Physics, a companion journal to the European Journal of Nuclear Medicine and Molecular Imaging (EJNMMI).
Abstracts Accepted at EANM and IPET Conferences Comparing Seracam® to Standard of Care Nuclear Medicine Imaging
London, UK, and Kuala Lumpur, Malaysia, 1 July 2024. Serac Imaging Systems Limited (“Serac Imaging Systems” or “the Company”), the medtech company developing a portable hybrid gamma-optical camera for medical imaging, and the University of Malaya Medical Centre, today announce that abstracts related to two ongoing clinical trials taking place in Malaysia using Seracam® have been accepted for presentation at key scientific meetings later this year.
First Use Of Seracam® In Image Guided Surgery
London, UK and Kuala Lumpur, Malaysia, 6 June 2024. Serac Imaging Systems Limited (“Serac Imaging
Systems” or “the Company”), the medtech company developing a portable hybrid gamma-optical
camera for medical imaging, and the University of Malaya Medical Centre, today announce the start
of clinical testing using Seracam® for image guided surgery in sentinel lymph node biopsy procedures
in patients with breast cancer.
Innovate UK grant awarded to develop Seracam® for image guided surgical oncology
London, UK, 26 March 2024. Serac Imaging Systems Limited (“Serac Imaging Systems” or “the
Company”), the medtech company developing Seracam®, a portable hybrid gamma-optical camera
for medical imaging, and Loughborough University announce that a grant has been awarded by
Innovate UK, the UK’s innovation agency, to Loughborough University to co-fund the development of
the camera for image guided surgery.
Icahn School of Medicine at Mount Sinai commences clinical testing with Seracam®
London, UK and New York, USA, 6 September 2023, Serac Imaging Systems Limited (“Serac Imaging Systems” or “the Company”), the medtech company developing Seracam®, a portable hybrid gamma-optical camera for medical imaging, and the Icahn School of Medicine at Mount Sinai, a ground-breaking leader in medical education, today announce the start of clinical testing using the Seracam® camera.
James Kaufman appointed as Chief Commercial Officer
London, UK, 20 June 2023. Serac Imaging Systems Limited (“Serac Imaging Systems” or “the Company”), the medical technology company developing Seracam®, a portable hybrid gamma-optical camera for medical imaging, today announces the appointment of James Kaufman as Chief Commercial Officer. James brings almost thirty years’ experience in the global healthcare and molecular imaging industry and will be responsible for leading on the commercialisation of Seracam®, reporting to Chief Executive, Mark Rosser.